A phenotypically distinct subset of immature B cells exhibits partial activation, increased survival, and preferential expression of VhS107

European Journal of Immunology

Volumn 33, Issue 12, 2003, Pages 3398-3408

  Wilson, Emily L ^a   Sherwood, Erin M ^a   King, Anne M ^a   Riley, Richard L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Activation; Apoptosis; CD43; Immature B cells; Repertoire

Indexed keywords

B LYMPHOCYTE RECEPTOR; CD11B ANTIGEN; CD5 ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; LEUKOSIALIN; PROTEIN TYROSINE KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE ACTIVATION; BONE MARROW; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; GENETIC HETEROGENEITY; IN VIVO STUDY; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD43; B-LYMPHOCYTES; BONE MARROW CELLS; CELL SURVIVAL; HEMATOPOIETIC STEM CELLS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN M; IMMUNOGLOBULIN VARIABLE REGION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; PHENOTYPE; PROTEIN ISOFORMS; SIALOGLYCOPROTEINS; SPLEEN;

EID: 0348013076     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324324     Document Type: Article

References (47)

1. Gay, D., Saunders, T., Camper, S. and Weigert, M., Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med. 1993. 177: 999-1008.
2. Tiegs, S. L., Russell, D. M. and Nemazee, D., Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 1993. 177: 1009-1020.
3. Kenny, J. J., Rezanka, L. J., Lustig, A., Fischer, R. T., Yoder, J., Marshall, S. and Longo, D. L., Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J. Immunol. 2000. 164: 4111-4119.
4. Li, H., Jiang, Y., Prak, E. L., Radic, M. and Weigert, M., Editors and editing of anti-DNA receptors. Immunity 2001. 15: 947-957.
5. Hartley, S. B., Cooke, M. P., Fulcher, D. A., Harris, A. W., Cory, S., Basten, A. and Goodnow, C. C., Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993. 72: 325-335.
6. Hayakawa, K., Asano, M., Shinton, S. A., Gui, M., Allman, D., Stewart, C. L., Silver, J. and Hardy, R. R., Positive selection of natural autoreactive B cells. Science 1999. 285: 113-116.
7. Kenny, J. J., Derby, E. G., Yoder, J. A., Hill, S. A., Fischer, R. T., Tucker, P. W., Claflin, J. L. and Longo, D. L., Positive and negative selection of antigen specific B cells in transgenic mice expressing variant forms of the Vh1 (T15) heavy chain. Int. Immunol. 2000. 12: 873-885.
8. + B cells both in vivo and in vitro. J. Immunol. 2000. 164: 4586-4593.
9. Arnold, L. W., McCray, S. K., Tatu, C. and Clarke, S. H., Identification of a precursor to phosphatidyl choline-specific B-1 cells suggesting that B-1 cells differentiate from splenic conventional B cells in vivo: cyclosporin A blocks differentiation to B-1. J. Immunol. 2000. 164: 2924-2930.
10. Tatu, C. and Clarke, S. H., Selective maturation of Vh12 B cells in the spleen enriches for anti-phosphatidyl choline B cells: evidence for receptor editing. Curr. Top. Microbiol. Immunol. 2000. 252: 77-86.
11. Burrows, P. D. and Cooper, M. D., B cell development and differentiation. Curr. Opin. Immunol. 1997. 9: 239-244.
12. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. and Hayakawa, K., Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 1991. 173: 1213-1225.
13. Wells, S. M., Kantor, A. B. and Stall, A. M., CD43 (S7) expression identifies peripheral B cell subsets. J. Immunol. 1994. 153: 5503-5515.
14. Gulley, M. L., Ogata, L. C., Thorson, J. A., Dailey, M. O. and Kemp, J. D., Identification of a murine pan-T cell antigen which is also expressed during the terminal phases of B cell differentiation. J. Immunol. 1988. 140: 3751-3757.
15. Hardy, R. R. and Hayakawa, K., B cell development pathways. Annu. Rev. Immunol. 2001. 19: 595-621.
16. Xu, H., Li, H., Suri-Payer, E., Hardy, R. R. and Weigert, M., Regulation of anti-DNA B cells in recombination-activating gene-deficient mice. J. Exp. Med. 1998. 188: 1247-1254.
17. Berland, R. and Wortis, H. H., Origins and functions of B-1 cells with notes on the role of CD5. Annu. Rev. Immunol. 2002. 20: 253-300.
18. Agate, Y., Kawasaki, A., Nishimura, H., Ishida, Y., Tsubata, T., Yagita, H. and Honjo, T., Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 1996. 8: 765-772.
19. Desiderio, S., Role of Btk in B cell development and signaling. Curr. Opin. Immunol. 1997. 9: 534-540.
20. Allman, D., Undsley, R. C., DeMuth, W., Rudd, K., Shinton, S. A. and Hardy, R. R., Resolution of three nonproliferative immature splenic B cell subsets reveal multiple selection points during peripheral B cell maturation. J. Immunol. 2001. 167: 6834-6840.
21. Rolink, A. G., Andersson, J. and Melchers, F., Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur. J. Immunol. 1998. 28: 3738-3748.
22. Loder, F., Mutschler, B., Ray, R. J., Paige, C. J., Sideras, P., Torres, R., Lamers, M. C. and Carsetti, R., B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 1999. 190: 75-89.
23. Healy, J. I. and Goodnow, C. C., Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 1998. 16: 645-670.
24. Sanderson, R. D., Lalor, P. and Bernfield, M., B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regulation 1989. 1: 27-35.
25. Okazaki, T., Maeda, A., Nishimura, H., Kurosaki, T. and Honjo, T., PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA 2001. 98: 13866-13871.
26. - B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int. Immunol. 1991. 3: 467-476.
27. MacLennan, I., B-cell receptor regulation of peripheral B cells. Curr. Opin. Immunol. 1998. 10: 220-225.
28. hi splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol. 1993. 151: 4431-4444.
29. Satterthwaite, A. B. and Witte, O. N., The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 2000. 175: 120-127.
30. Merino, R., Ding, L., Veis, D. J., Korsmeyer, S. J. and Nunez, G., Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J. 1994. 13: 683-691.
31. Benedict, C. L., Giffillan, S., Thai, T.-H. and Kearney, J. F., Terminal deoxynucleotidyl transferase and repertoire development. Immunol. Rev. 2000. 175: 150-157.
32. L epitopes. Mol. Immunol. 1984. 21: 961-967.
33. Hardy, R. R. and Hayakawa, K., CD5 B cells, a fetal B cell line-age. Adv. Immunol. 1994. 55: 297-339.
34. Hamilton, A. M., Lehuen, A. and Kearney, J. F., Immunofluorescence analysis of B-1 cell ontogeny in the mouse. Int. Immunol. 1994. 6: 355-361.
35. Hardy, R. R., Li, Y.-S., Allman, D., Asano, M., Gui, M. and Hayakawa, K., B-cell commitment, development and selection. Immunol. Rev. 2000. 175: 23-32.
36. Buhl, A. M., Nemazee, D., Cambier, J. C., Rickert, R. and Hertz, M., B-cell antigen receptor competence regulates B-lymphocyte selection and survival. Immunol. Rev. 2000. 176: 141-153.
37. Pospisil, R. and Mage, R. G., CD5 and other superantigens as "ticklers" of the B cell receptor. Immunol. Today 1998. 19: 106-108.
38. Potter, M. and Melchers, F., Opinions on the nature of B-1 cells and their relationship to B cell neoplasia. Curr. Top. Microbiol. Immunol. 2000. 252. 307-324.
39. Dragone, L., Barth, R., Sitar, K., Disbrow, G. and Frelinger, J., Disregulation of leukosialin (CD43, Ly48, sialophorin) expression in the B cell lineage of transgenic mice increases splenic B cell number and survival. Proc. Natl. Acad. Sci. USA 1995. 92: 626-630.
40. Misawa, Y., Nagaoka, H., Kimoto, H., Kitamura, K., Tsunetsugu-Yokota, Y., Shibuya, M. and Takemori, T, CD43 expression in a B cell lymphoma, WEHI 231, reduces susceptibility to G1 arrest and extends survival in culture upon serum depletion. Eur. J. Immunol. 1996. 26: 2573-2581.
41. Dillon, S. R., Constantinescu, A. and Schlissel, M. S., Annexin V binds to positively selected B cells. J. Immunol. 2001. 166: 58-71.
42. Hardy, R., Hayakawa, K., Parks, D., Herzenberg, L. and Herzenberg, L., Murine B cell differentiation lineages. J. Exp. Med. 1984. 159: 1169-1188.
43. Hayakawa, K., Hardy, R., Herzenberg, L. and Herzenberg, L., Progenitors for Ly-1 B cells are distinct from progenitors for other B cells. J. Exp. Med. 1985. 161: 1554-1568.
44. Haughton, G., Arnold, L. W., Whitmore, A. C. and Clarke, S. H., B-1 cells are made, not born. Immunol. Today 1993. 14: 84-87.
45. Lam, K.-P. and Rajewsky, K., B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J. Exp. Med. 1999. 190: 471-477.
46. Wortis, H. H., Teutsch, M., Higer, M., Zheng, J. and Parker, D. C., B-cell activation by crosslinking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc. Natl. Acad. Sci. USA 1995. 92: 3348-3352.
47. Huang, C. A., Henry, C., Iacomini, J., Imanishi-Kari, T. and Wortis, H. H., Adult bone marrow contains precursors for CD5+ B cells. Eur. J. Immunol. 1996. 26: 2537-2540.